This public procurement record has 3 releases in its history.

Award

26 Oct 2026 at 15:36

Tender

15 Jul 2026 at 11:45

Planning

26 Jun 2026 at 12:27

Summary of the contracting process

The UK Health Security Agency, acting for the Secretary of State for Health and Social Care, procured the supply of heptavalent botulinum antitoxin, a pharmaceutical product for use in the United Kingdom. The requirement concerns supply of the antitoxin rather than a wider treatment or clinical service. The procurement was arranged as a single lot, covering delivery across the UK. This is a specialist medicine supply requirement, with product quality, reliable supply and compliant licensing central to the buyer’s needs. The process has concluded with a supplier selected; the award is recorded as pending, and the contract signature was scheduled to follow the standstill period.

The competition used an open competitive flexible procedure, with full tenders assessed first and an optional single negotiation round available. One bid was received. Emergent BioSolutions Canada Inc was selected for the single lot, with an award date of 26 October 2026 and an award value recorded as £1. The planned contract period is 16 November 2026 to 15 November 2028, with an option for one or two one-year renewals, up to 15 November 2030. The tender deadline was 13 August 2026; the question deadline was 30 July 2026. Evaluation weighted commercial price at 80%, social value at 10%, and technical risk at 10%. Tenderers had to sign a non-disclosure agreement before accessing the tender documents.

For suppliers considering future UKHSA requirements for heptavalent botulinum antitoxin, this award indicates a specialist pharmaceutical supply opportunity where regulatory compliance is essential: the buyer expressly required compliant licensing. A credible competitor would need to demonstrate the ability to provide the required product, maintain product quality and shelf life, and meet dependable delivery schedules. Proposals were also expected to address supply risk and business continuity, alongside commercial pricing and contractual flexibility. Social value formed part of the assessment, although price carried the largest weighting. The single-lot structure and UK-wide delivery requirement point to the need for national supply capability rather than a local service operation. The award went to a large Canadian supplier, while the lot was marked as suitable for SMEs, so smaller businesses may be relevant if they can meet the licensing, continuity and delivery demands.

How relevant is this notice?

Notice Information

Notice Title

Botulinum Antitoxin Heptavalent (2026)

Notice Description

The supply of Botulinum Antitoxin Heptavalent

Planning Information

Suppliers are invited to submit responses including the following: Product Information: - Product name and description - Available dose/pack sizes and formats - Any minimum order quantities Lead Times and Supply: - Standard lead times based on contract starting September 2026 If your organisation is interested in this requirement, please provide the above information to commercial.preparednessandcountermeasures@ukhsa.gov.uk by COP 10th July 2026. Once the tender is published, bidders will be required to sign a Non-Disclosure Agreement (NDA) prior to gaining access to the tender documentation.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06be1b
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/101152-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Competitive flexible procedure
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1
Lots Value
£1
Awards Value
£1
Contracts Value
Not specified

Notice Dates

Publication Date
26 Oct 20263 weeks ago
Submission Deadline
13 Aug 2026Expired
Future Notice Date
17 Jul 2026Expired
Award Date
26 Oct 20263 weeks ago
Contract Period
16 Nov 2026 - 15 Nov 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
UK Health Security Agency
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Postcode Area
East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified

Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Supplier Information

Number of Suppliers
1
Supplier Name

Emergent Biosolutions Canada Inc

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...